ActX is integrated with Veradigm EHR and Alterra TouchWorks.

ActX makes it possible for the first time to bring the power of Actionable Genomics℠ into your practice, beginning the era of Precision Medicine.

igned for the busy clinician, who does not have to be an expert in medical genetics.

Integrated into Veradigm EHR (formerly Allscripts Professional EHR) and Altera Touchworks (formerly Allscripts Touchworks), every time your physicians write a prescription, ActX checks the drug against the patient's genetics, alerting them only if there is an issue with adverse effects, efficacy or dosing. ActX covers almost all U.S. prescription drugs for which there is evidence of a genomic effect. For example, a significant percentage of the U.S. population likely gets no pain relief from codeine, based on their genetics, and ActX can alert your clinicians to these patients.

Inside your Veradigm or Altera electronic chart, the ActX Patient Genomic Profile shows actionable patient genomic risks. For example, patients with Lynch syndrome, a genetic condition, can have up to a 70% lifetime risk of colorectal cancer, which can be detected at an early stage through colonoscopy starting at a young age.

The ActX Service is evidence based, is continuously updated, includes references, and evaluates the strength of the evidence and the quality of the patient data.

In addition to providing real-time Genomic Decision Support℠, ActX makes it easy to obtain your patient's genetics using a small amount of saliva. It is a full turn-key solution. A physician authorizes a patient for the ActX Service by pressing the ActX Auth button and confirming the patient's email address. After authorization, your patient will receive an email allowing them to sign up for the ActX Service. The patient will then sign up on the ActX website, pay for the service (the service is currently paid for by patients and not covered by insurance), and receive a saliva collection kit at their home. The patient spits 1 cc into a tube and then mails it directly to our CLIA-certified laboratory, where it will be genotyped or sequenced.

After quality assurance, the ActX Genomic Decision Support service will be activated. The authorizing physician will be alerted by a new task when the patient's data is available, and when any immediate or subsequent serious medical risks are found. Every time a prescription is written, it will be checked for drug-genome interactions, and an up-to-date patient Genomic Profile can be checked in Veradigm or Altera at any time.

To order the ActX Service, please email info@actx.com.